Global Nuclear Medicine Market Analysis by Type, Application, Growth rate, Company Analysis and Outlook Period Until 2023

Posted on 2019-04-29 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, 2019-Apr-29 — /EPR Network/ —This research report titled “Global Nuclear Medicine Market” has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Nuclear Medicine Market during the period 2013 and 2023. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in order to enlighten the readers about the actual scenario prevailing in the Nuclear Medicine Market.

Request Sample Copy of the Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2287044

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Nuclear Medicine Market. The report analyzes the Nuclear Medicine Market By Product (Therapeutic, Diagnostic), By Diagnostics (SPECT, PET), By Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy) and By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others). The Nuclear Medicine Market has been analyzed By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, France, Germany, India, China, Japan and Brazil) for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report “Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) – By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)”, global market is projected to display a robust growth represented by a CAGR of 10.07% during 2018 – 2023.

The indication segment of Oncological disorders has been witnessing growth at a noteworthy rate over the past few years backed by increased prevalence of cancer, presence of technical advance PET and SPECT equipment to perform treatment, rising number of nuclear centers Amongst the regions, North America accounts for the largest regional share in the global nuclear medicine market in 2018. Key factors driving the robust growth rate of North America region include well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of chronic ailment such as cardiovascular disorders, neurological disorders etc. in the region.

The report titled “Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) – By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)” has covered and analyzed the potential of Global Nuclear Medicine and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global nuclear medicine devices market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Nuclear Medicine Market (Actual Period: 2013-2017, Forecast Period: 2018-2023
• Global Nuclear Medicine Market – Size, Growth, Forecast
• By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)
• By Product Type (Diagnostic, Therapeutic)
• By Diagnostic Type (SPECT, PET)
• By Therapeutic Type (Alpha Emitters, Beta emitters, Brachytherapy)

Regional Markets – North America, Europe, APAC and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Nuclear Medicine Market – Size and Growth
• By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)
• By Product Type (Diagnostic, Therapeutic)
• By Diagnostic Type (SPECT, PET)
• By Therapeutic Type (Alpha Emitters, Beta emitters, Brachytherapy)

Country Analysis – U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil)
• Nuclear Medicine Market – Size and Growth
• By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)

Other Report Highlights
• Market Dynamics – Drivers and Restraints
• Market Trends
• Porter Five Force Analysis
• Policy and Regulatory Landscape
• Competitive Landscape
• Company Analysis – Bracco Imaging, Lantheus Holding, Curium, Jubilant Lifesciences, 3B Pharmaceutical Cardinal Health Advanced Accelerator Application, Eckert & Ziegler

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/global-nuclear-medicine-market-report.html

Research Methodology

Executive Summary

Strategic Recommendations

Nuclear Medicine Market Overview

Global Nuclear Medicine : Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

Global Nuclear Medicine Market: By Indication
6.1 Global Nuclear Medicine Market-By Product Type: Breakdown(%)
6.1.1 Global Nuclear Medicine Market Size and Share, By Product Type, 2017
6.1.2 Global Nuclear Medicine Market Size and Share, By Product Type, 2023
6.2 Global Diagnostic Nuclear Medicine Market Overview
6.2.1 By Value (2013-2023)
6.3 Global Therapeutic Nuclear Medicine Market Overview
6.3.1 By Value (2013-2023)

Global Nuclear Medicine Market: By Therapeutic Type
7.1 Global Nuclear Medicine Market: By Therapeutic Type : Breakdown(%)
7.1.1 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type , 2017
7.1.2 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type ,2023
7.2 Global Beta Emitters Nuclear Medicine Market Overview
7.2.1 By Value (2013-2023)
7.3 Global Alpha Emitters Nuclear Medicine Market Overview
7.3.1 By Value (2013-2023)
7.4 Global Brachytherapy Nuclear Medicine Market Overview
7.4.1 By Value (2013-2023)

Continued……….@#

Enquire about this report@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2287044

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick